HEMGENIX® (etranacogene dezaparvovec-drlb) | How HEMGENIX Works HEMGENIX is the first-ever FDA-approved gene therapy for hemophilia B A one-time infusion could offer elevated factor IX levels for years Please see Important Safety Information and full Prescribing Information on website
HEMGENIX® (etranacogene dezaparvovec-drlb) | Official Website for . . . HEMGENIX is the first ever FDA approved gene therapy for hemophilia B By addressing the root cause, it offers elevated FIX levels for years Please see Important Safety Information and full Prescribing Information on website
HEMGENIX® (etranacogene dezaparvovec-drlb) | How HEMGENIX Works HEMGENIX (etranacogene dezaparvovec-drlb) combines a liver-directed AAV5 vector, the highly active factor IX-Padua gene variant, and a liver-specific promoter Please see Important Safety Information and full Prescribing Information on website
WHY GENE THERAPY FOR HEMOPHILIA B? - HEMGENIX HEMGENIX ®, etranacogene dezaparvovec-drlb, is an adeno-associated virus vector-based gene therapy indicated for the treatment of adults with Hemophilia B (congenital Factor IX deficiency) who:
HEMGENIX® (etranacogene dezaparvovec-drlb)| Resources and FAQs Find resources about HEMGENIX services and treatment options Read the answers to some frequently asked questions about HEMGENIX Please see Important Safety Information and full Prescribing Information on website
HEMGENIX® (etranacogene dezaparvovec-drlb) | Dosing and Administration Learn about storing and handling HEMGENIX, how to prepare for administration, and what to do during and after the infusion of HEMGENIX Please see Important Safety Information and full Prescribing Information on website